<DOC>
	<DOCNO>NCT00021242</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , docetaxel , work different way stop cancer cell divide stop grow die . PURPOSE : Phase II trial study effectiveness docetaxel treat child relapse refractory acute lymphoblastic acute myeloid leukemia .</brief_summary>
	<brief_title>Docetaxel Treating Children With Relapsed Refractory Acute Lymphoblastic Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate pediatric patient relapse refractory acute lymphoblastic acute myeloid leukemia treat docetaxel . - Determine toxicity regimen patient . OUTLINE : Patients receive docetaxel IV 1 hour day 1 , 8 , 15 . Treatment repeat every 28 day maximum 12 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 10-20 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm acute lymphoblastic acute myeloid leukemia M3 bone marrow relapse require Refractory conventional chemotherapy No extramedullary disease relapse PATIENT CHARACTERISTICS : Age : 21 time initial diagnosis Performance status : ECOG 02 Life expectancy : At least 2 month Hematopoietic : Not specify Hepatic : Bilirubin great 1.5 mg/dL AST ALT great 1.5 time normal Alkaline phosphatase great 2.5 time normal Renal : Creatinine great 1.5 time normal OR Creatinine clearance radioisotope glomerular filtration rate least 70 mL/min Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 7 day since prior biologic therapy recover At least 6 month since prior allogeneic stem cell transplantation No concurrent immunomodulating agent first 2 course therapy No concurrent routine filgrastim ( GCSF ) Chemotherapy : See Disease Characteristics At least 2 week since prior chemotherapy ( 4 week nitrosoureas ) recover No prior paclitaxel docetaxel No concurrent chemotherapy first 2 course therapy Endocrine therapy : No concurrent corticosteroid therapy except dexamethasone , lowdose hydrocortisone treat allergic reaction , treatment adrenal crisis Radiotherapy : Recovered prior radiotherapy At least 2 week since prior palliative local radiotherapy At least 6 month since prior craniospinal radiotherapy radiotherapy least 50 % pelvis At least 6 week since prior substantial bone marrow radiotherapy No concurrent radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
</DOC>